Delta4 Phantom+ and HexaMotion Support Hitachi OXRAY Commissioning

Delta4 Phantom+ and HexaMotion are supporting commissioning and quality assurance (QA) for a Hitachi OXRAY linear accelerator in Japan, demonstrating how independent measurement systems contribute to the introduction of new radiotherapy technologies.

Commissioning and QA for New Radiotherapy Technologies

Introducing a new treatment platform requires thorough verification of its performance before clinical use.

Delta4 Phantom+ provides independent 3D dose measurements, while HexaMotion adds the capability to simulate patient breathing and tumor motion independently. Together, the systems support dose verification and motion management QA as clinics commission new equipment and treatment techniques.

This early Hitachi OXRAY installation in Japan highlights the role of independent QA in bringing new radiotherapy technologies into clinical practice.

Learn more about Delta4 Phantom+ and HexaMotion

💡 Interested in learning how Delta4 Phantom+ with HexaMotion supports patient QA for Hitachi OXRAY?  Contact us!

Note to our readers: We strictly respect the privacy of our clinical partners and only share installation news with permission. While this represents only a small snapshot of our global installations, we are grateful to the clinics that allow us to highlight our partnership and share these updates with the community.